Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at CZK 2.09T, ahead of Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.44T). Figures as of 19 Nov 2026, 00:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonCZK 2.09T
- Median
- CZK 71.1B
- Combined market value
- CZK 112.38T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 2.09T | CZK 14.58T | CZK 6,057.49 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | CZK 1.45T | CZK 27.36T | CZK 30,715.03 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | CZK 1.44T | CZK 7.54T | CZK 3,060.51 | 3.90% down | 51% up | ||
| 4 | PfizerPFE · Health Care | CZK 1.39T | CZK 3.55T | CZK 623.30 | 1.44% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | CZK 1.36T | CZK 11.23T | CZK 6,353.14 | 2.33% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | CZK 1.3T | CZK 6.16T | CZK 3,970.80 | 1.93% down | 2% up | ||
| 7 | NovartisNVS · Health Care | CZK 1.21T | CZK 6.51T | CZK 3,447.68 | 2.46% down | 25% up | ||
| 8 | SanofiSNY · Health Care | CZK 1.08T | CZK 2.51T | CZK 1,046.68 | 0.86% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | CZK 1.07T | CZK 2.7T | CZK 1,323.01 | 2.92% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | CZK 1.02T | CZK 3.86T | CZK 875.86 | 3.12% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | CZK 984.7B | CZK 4.02T | CZK 2,320.81 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | CZK 963.2B | CZK 2.16T | CZK 1,079.11 | 1.34% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | CZK 626.8B | CZK 1.51T | CZK 472.47 | 1.71% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 383.4B | CZK 1.09T | CZK 938.05 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CZK 318.6B | CZK 2.17T | CZK 21,003.06 | 1.28% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | CZK 317.6B | CZK 516.5B | CZK 450.48 | 0.83% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CZK 266.6B | CZK 3.02T | CZK 11,916.16 | 0.42% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | CZK 210.3B | CZK 772.3B | CZK 1,900.77 | 2.50% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | CZK 185.4B | CZK 128B | CZK 188.14 | 1.85% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | CZK 118.7B | CZK 1.02T | CZK 8,965.17 | 2.34% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | CZK 104.7B | CZK 296.4B | CZK 593.09 | 3.29% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 94.8B | CZK 353.3B | CZK 5,503.72 | 2.93% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | CZK 82.6B | CZK 698.1B | CZK 1,132.20 | 1.91% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | CZK 82.5B | CZK 444.5B | CZK 3,318.62 | 4.54% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 79.4B | CZK 277.4B | CZK 332.75 | 1.28% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CZK 71.6B | CZK 264.3B | CZK 1,364.54 | 4.99% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | CZK 70.7B | CZK 546.2B | CZK 12,824.45 | 1.16% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | CZK 67.1B | CZK 169.3B | CZK 486.02 | 3.60% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | CZK 52.8B | CZK 877.1B | CZK 1,525.37 | 0.01% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | CZK 38.4B | CZK 111.8B | CZK 1,337.89 | 0.22% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | CZK 32.8B | CZK 174.9B | CZK 1,040.68 | 3.08% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | CZK 22.9B | CZK 70B | CZK 360.96 | 0.87% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 21.3B | CZK 205.4B | CZK 8,842.55 | 5.67% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | CZK 21B | CZK 101.3B | CZK 608.41 | 1.59% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 18.4B | CZK 135.4B | CZK 957.60 | 0.28% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | CZK 17.7B | CZK 393.9B | CZK 6,004.84 | 0.32% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | CZK 16.9B | CZK 164.8B | CZK 1,505.82 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 15.1B | CZK 165.9B | CZK 2,111.35 | 0.06% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | CZK 14.2B | CZK 156.6B | CZK 2,976.54 | 1.43% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | CZK 13.7B | CZK 222B | CZK 1,468.72 | 5.44% up | 107% up | ||
| 41 | InsmedINSM · Health Care | CZK 13.5B | CZK 583.8B | CZK 2,661.12 | 1.69% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.6B | CZK 134.1B | CZK 2,054.48 | 0.59% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | CZK 11.2B | CZK 337.6B | CZK 1,732.84 | 1.58% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 107.1B | CZK 1,115.98 | 1.68% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | CZK 6B | CZK 132.7B | CZK 6,635.25 | 1.67% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.2B | CZK 183.3B | CZK 2,644.24 | 2.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | CZK 2B | CZK 158.8B | CZK 1,139.97 | 0.64% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | CZK 1B | CZK 184.4B | CZK 2,824.61 | 2.00% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | CZK 183.5M | CZK 623.3B | CZK 860.31 | 0.05% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | CZK 45.2M | CZK 105B | CZK 1,865.45 | 3.45% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | CZK 0 | CZK 214B | CZK 2,253.73 | 8.15% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | CZK 0 | CZK 189.5B | CZK 6,779.19 | 0.04% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2130 CZK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (CZK 2.09T), Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.44T) are the top three of the 52 pharmaceutical companies ranked by revenue as of 19 Nov 2026, 00:16 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of CZK 112.38T as of 19 Nov 2026, 00:16 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.